INT242203

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.04
First Reported 2008
Last Reported 2008
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0.64
Pain Relevance 0.10

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

small molecule metabolic process (GLP1R, GCG) plasma membrane (GLP1R, GCG) cell proliferation (GCG)
signal transduction (GCG) extracellular space (GCG) extracellular region (GCG)
GLP1R (Homo sapiens)
GCG (Homo sapiens)
Pain Link Frequency Relevance Heat
agonist 2 100.00 Very High Very High Very High
Inflammation 4 5.00 Very Low Very Low Very Low
Pain 1 5.00 Very Low Very Low Very Low
Inflammatory response 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Diabetes Mellitus 104 97.92 Very High Very High Very High
Hyperglycemia 12 91.20 High High
Cardiovascular Disease 50 89.88 High High
Hypoglycemia 17 86.92 High High
Weight Gain 16 51.92 Quite High
Myocardial Infarction 24 18.80 Low Low
Obesity 12 5.00 Very Low Very Low Very Low
Disease 12 5.00 Very Low Very Low Very Low
Pressure And Volume Under Development 8 5.00 Very Low Very Low Very Low
Stroke 8 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
For example, glucagon-like peptide 1 (GLP-1) analogs, GLP-1 agonists and dipeptidyl peptidase IV (DPP-4) inhibitors represent very promising treatment options for patients with T2DM.
GLP-1 Regulation (represent) of glucagon-like peptide 1 associated with diabetes mellitus and agonist
1) Confidence 0.04 Published 2008 Journal Vascular Health and Risk Management Section Body Doc Link PMC2515417 Disease Relevance 0.64 Pain Relevance 0.10

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox